H.C. Wainwright analysts have reduced the price target for ALX Oncology (NASDAQ:ALXO) shares to $5 from the previous $25 ...

Cantor Fitzgerald reaffirmed its Overweight rating on ALX Oncology (NASDAQ:ALXO), following the presentation of positive Phase 2 ASPEN-6 study results. According to InvestingPro data, the company's ...

AbbVie and Neomorph are set to enter a partnership and option-to-license agreement to develop molecular glue degraders.

A new statistical tool that combines multiple clinical and pathologic factors with a patient's 21-gene Oncotype DX Breast ...

David M. Waterhouse, MD, MPH, and Molly Mendenhall, MBOE, LSSBB, BSN, RN, discuss how the implementation of Lean Six Sigma methodology at Oncology Hematology Care in Cincinnati, Ohio, has transformed ...

Prostate cancer presents challenges in detection, treatment, and management. Learn about genetic risks, treatment resistance, ...

Imagine a career in a field you can’t imagine. Dominique Constantini parlayed her commitment to immunology to meeting unmet ...

Predictive Oncology Inc (POAI) stock saw a modest uptick, ending the day at $1.48 which represents a slight increase of $0.21 or 16.54% from the prior close of $1.27. The stock opened at $1.58 and ...

Researchers identified a 15-year shift toward surgical de-escalation in gynecologic oncology, marked by fewer surgical ...

The Precision Oncology Showcase is a webinar series sponsored by SOPHiA GENETICS, set to redefine how precision oncology is ...

Some six and a half years since its debut, Servier’s U.S. arm has made good on its oncology growth ambitions while managing to stay true to its patient-centric ethos along the way. | Some six and a ...

Dr. Victoria Forte has been appointed chief of the Division of Hematology/Oncology, Cancer Service Line director, and ...